RxDoctor Payments Data

Jorge Kusnir

Nephrology · Orlando, FLNPI 1063405108

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $1,594 of the $2,376 with a category attached, or 67.1%. Vertex accounts for 69.5% of it on its own, with 4 other manufacturers making up the rest.

$2,376in general payments, 2019–2025

Across 17 payments — averaging $139.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Vertex$2K
  • Astrazeneca UK Limited$396
  • Amgen$125
  • Baxter Healthcare$120
  • Travere Therapeutics, Inc.$85
$1,961,939in research payments, 2019–2025

Across 264 payments — averaging $7431.59 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AbbVie$814K
  • GSK$475K
  • Astrazeneca UK Limited$420K
  • Akebia Therapeutics Inc$108K
  • Dynavax Technologies Corporation$63K
  • Travere Therapeutics, Inc.$39K
  • plus $45K from 7 others

What the payments were for

  • Travel & lodging$1,59467%
  • Food & beverage$78233%

General payments by program year

19
20

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,376 in reported general payments places this provider in the 60th percentile of 756 nephrology providers in Florida.

See all nephrology providers in Florida

Other nephrology in Orlando

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →